domingo, 10 de marzo de 2019

Is it ever ethical to withdraw treatment from patients with a persistent disorder of consciousness?

Is it ever ethical to withdraw treatment from patients with a persistent disorder of consciousness?

Bioedge

Is it ever ethical to withdraw treatment from patients with a persistent disorder of consciousness?
     
There has been significant debate in recent years about the ethics of withdrawing life-sustaining treatment from patients with prolonged disorders of consciousness (PDOCs). Some examples of PDOCs include patients in a minimally conscious state and those in a persistent vegetative state.
Prevailing wisdom in both law and ethics suggests that decisions about treatment withdrawal should primarily be determined by patients themselves, and, specifically, prior statements that patients have made about their treatment preferences.
Ethicists have also argued that the low quality of life of PDOC patients, and the high cost of continuing life support, may give us reason to withdraw treatment from patients who have little prospect of recovery.
Yet a provocative new article published in the Journal of Medical Ethics directly challenges prevailing opinion on how to treat PDOC patients. University of Oxford Professor of Law Charles Foster argues that it is never ethical (nor, from the perspective of British law, legal) to withdraw treatment from patients with PDOCs.
Foster notes that in British law there is a strong presumption in favour of the continued life of a patient with deep and prolonged impairment of consciousness. The author quotes Baroness Hale, who in Aintree University Hospitals NHS Foundation Trust v James [2014], stated that:
“The authorities are all agreed that the starting point is a strong presumption that it is in a person’s best interests to stay alive”.
Foster contends that it would take a very strong legal, medical, or ethical argument to nullify this presumption. Yet such arguments have not been forthcoming.
Sometimes it is argued that the many patients in a minimally conscious or permanent vegetative state have very little prospect of recovery. Yet Foster is sceptical about the reliability of the data on such patients. He writes that diagnosis of PDOCs is “notoriously difficult”, and that there is only a “tenuous basis” for estimates about the likelihood and speed of recovery of patients with a PDOC.
Foster is suspicious of the view that the presence of consciousness in PDOC patients provides a reason for the withdrawal of treatment. He argues that, from both a legal and ethical point of view, we should not dismiss the quality of life of patients in a PVS state. He writes:
For all we know, patients in PDOC might be in a profoundly peaceful state of optimal self-realisation, and feel no need to express their consciousness in the exuberantly detectable ways that we more frenetically conscious creatures do. This might sound ridiculous, but unless it is demonstrably ridiculous (and it plainly is not), the legal consequence is, and the ethical consequence should be, that life should be preserved.
He even provides reason to be suspicious of the previously expressed wishes of patients. We cannot know what it is like to have a PDOC, the author suggests, precisely because it entails a completely different state of consciousness, or no consciousness at all:
...changes in brain function that occur when a patient is in PDOC plunge the patient into a condition the nature of which is unknown and (at least at present) unknowable.
We should, therefore, not consider a patient’s statements about treatment preferences to be binding.
The article has already attracted significant attention in academic circles, and is likely to garner several responses from critics.
Xavier Symons is deputy editor of BioEdge
Bioedge

It often takes a newsworthy tragedy to make us think deeply about difficult ethical issues. One example is our lead story this week. The parents of a brain-damaged West Point cadet, Peter Zhu, asked a court to order a hospital to retrieve his sperm so that the family name can be carried on. No sooner said than done. Justice John P. Colangelo, of the New York Supreme Court, Ninth Judicial District, directed Westchester Medical Center to collect the sperm and have it stored. A court hearing will be held on March 21.

The outcome of this case will be interesting, partly because it pits ethics based on family ties against ethics based on personal autonomy. Peter’s parents know that they cannot get their son back, but they believe that they have a right to a possible child to carry on the family name. But bioethicists point out that grandparents do not have a right to a grandchild and that Peter never consented to such a procedure. A family's tragic loss is shaping up as a clash of cultures, collective versus individualistic, Asian versus Western.



m.png
Michael Cook
Editor
BioEdge
 Comment on BioedgeFind Us on FacebookFollow us on Twitter
NEWS THIS WEEK

by Michael Cook | Mar 10, 2019
They plead for family line not to be extinguished

by Michael Cook | Mar 10, 2019
Often they are not treated by psychiatrists

by Michael Cook | Mar 10, 2019
Boy in Oregon nearly died from tetanus – but his parents still won’t vaccinate him

by Michael Cook | Mar 10, 2019
Philosophers can clarify many subtle scientific concepts

by Michael Cook | Mar 10, 2019
No single government agency is responsible for checking

by Xavier Symons | Mar 10, 2019
Transcranial brain stimulation may have serious side-effects, ethicists say.
IN DEPTH THIS WEEK

by Lee McIntyre | Mar 09, 2019
Embracing uncertainty and doubt is a better strategy for fighting science denial in the long run.
Bioedge

BioEdge
Suite 12A, Level 2 | 5 George St | North Strathfield NSW 2137 | Australia
Phone: +61 2 8005 8605
Mobile: 0422-691-615

No hay comentarios: